These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 10203263)

  • 21. The Challenge of Developing New Therapies for Childhood Cancers.
    Balis FM
    Oncologist; 1997; 2(1):I-II. PubMed ID: 10388032
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evolving treatment approaches for early breast cancer.
    Campos SM
    Breast Cancer Res Treat; 2005; 89 Suppl 1():S1-7. PubMed ID: 15770534
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy.
    Li X; Lewis MT; Huang J; Gutierrez C; Osborne CK; Wu MF; Hilsenbeck SG; Pavlick A; Zhang X; Chamness GC; Wong H; Rosen J; Chang JC
    J Natl Cancer Inst; 2008 May; 100(9):672-9. PubMed ID: 18445819
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Drug therapy of breast carcinoma].
    Dittrich C
    Wien Med Wochenschr; 2000; 150(4):72-86. PubMed ID: 10829307
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carboplatin in combination therapy for metastatic breast cancer.
    Perez EA
    Oncologist; 2004; 9(5):518-27. PubMed ID: 15477636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adjuvant treatment of high-risk stage II breast cancer with doxorubicin followed by high-dose chemotherapy and autologous stem-cell transplantation: a single-institution experience with 132 consecutive patients.
    Stemmer SM; Hardan I; Raz H; Adamou AK; Inbar M; Gottfried M; Merrick Y; Cohen Y; Sulkes A; Ben-Baruch N; Pfeffer RP; Brenner HJ; Rizel S
    Bone Marrow Transplant; 2003 Apr; 31(8):655-61. PubMed ID: 12692605
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Primary chemotherapy in operable breast carcinoma].
    Bonadonna G; Valagussa P
    Ann Ital Chir; 1999; 70(3):359-69. PubMed ID: 10466239
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dose and schedule as determinants of outcomes in chemotherapy for breast cancer.
    Budman DR
    Semin Oncol; 2004 Dec; 31(6 Suppl 15):3-9. PubMed ID: 15726532
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug resistance in chemotherapy for breast cancer.
    Saeki T; Tsuruo T; Sato W; Nishikawsa K
    Cancer Chemother Pharmacol; 2005 Nov; 56 Suppl 1():84-9. PubMed ID: 16273361
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New concepts in breast cancer therapy.
    Snyder RD
    Intern Med J; 2004 May; 34(5):266-9. PubMed ID: 15151673
    [TBL] [Abstract][Full Text] [Related]  

  • 32. National Institutes of Health Consensus Development Conference statement: adjuvant therapy for breast cancer, November 1-3, 2000.
    National Institutes of Health Consensus Development Panel
    J Natl Cancer Inst Monogr; 2001; (30):5-15. PubMed ID: 11773285
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Kinetics of breast neoplasms].
    Surbone A; Norton L
    Minerva Med; 1994; 85(1-2):7-16. PubMed ID: 8152580
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Concepts and clinical trials of dose-dense chemotherapy for breast cancer .
    Orzano JA; Swain SM
    Clin Breast Cancer; 2005 Dec; 6(5):402-11. PubMed ID: 16381623
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Future directions in the therapy for large bowel cancer.
    Carter SK
    Cancer; 1982 Dec; 50(11 Suppl):2647-56. PubMed ID: 6182979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adjuvant therapy for breast cancer.
    Margolese RG
    Can J Surg; 1981 May; 24(3):293-4, 299. PubMed ID: 7016288
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dose-dense chemotherapy for breast cancer: what does the future hold?
    Morris PG; McArthur HL; Hudis C; Norton L
    Future Oncol; 2010 Jun; 6(6):951-65. PubMed ID: 20528233
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conclusions: future strategies in the treatment of breast cancer.
    Piccart MJ; Hortobagyi GN
    Semin Oncol; 1997 Feb; 24(1 Suppl 3):S34-40. PubMed ID: 9071339
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New approaches to the treatment of advanced breast cancer.
    Eckardt JR
    Anticancer Drugs; 1996 Aug; 7 Suppl 2():41-6. PubMed ID: 8862711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conceptual basis for advances in the systemic drug therapy of breast cancer.
    Norton L
    Semin Oncol; 1997 Aug; 24(4 Suppl 11):S11-2-S11-12. PubMed ID: 9314292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.